Advertisement

Topics

Moffitt Cancer Center and Cvergenx partner to personalize radiation therapy

20:00 EDT 8 Aug 2017 | AAAS

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt's Radiation Oncology Department will utilize Cvergenx's Genomic-Adjusted Radiation Dose (GARD) model.

Original Article: Moffitt Cancer Center and Cvergenx partner to personalize radiation therapy

NEXT ARTICLE

More From BioPortfolio on "Moffitt Cancer Center and Cvergenx partner to personalize radiation therapy"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...